New formulation concepts designed to improve the efficacy and refine the usability of acne care formulations with scientific and sensory benefits BRIDGEWATER, New Jersey, February 1, 2017 – A new anti-acne formulation kit from Ashland is available to help formulators of cosmetic and
Loss from continuing operations attributable to Ashland was $0.01 per diluted share, compared to earnings of $1.38 per diluted share in the year-ago period Adjusted earnings from continuing operations attributable to Ashland totaled $1.16 per diluted share, compared to $1.41 in the year-ago period
COVINGTON, KY , January 26, 2017 - The board of directors of Ashland Global Holdings Inc. ( NYSE : ASH) has declared a quarterly cash dividend of $0.39 per share on the company's common stock. The dividend is payable March 15, 2017 , to shareholders of record at the close of business on March 1,
COVINGTON, Ky. , January 12, 2017 - Ashland ( NYSE : ASH) today said it plans to report financial results for the first quarter of fiscal 2017 after the New York Stock Exchange closes Thursday, January 26, 2017 , and to host a webcast with investors the following morning.
COVINGTON, KY , December 27, 2016 - Ashland Global Holdings Inc. ( NYSE : ASH) ("Ashland") today announced the final tender results and final settlement of the previously announced cash tender offer (the "Tender Offer") by its wholly-owned subsidiary, Hercules LLC (formerly Hercules Incorporated )